Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Megan Urquhart

Physician Assistant Rolling Meadows, IL Physician Assistant

NPI 1790313146 CMS profile 11254679

5301 Keystone Ct, Rolling Meadows, IL 60008

Open in the dashboard

General payments

$8,083

337 records reported · program years 2021–2025

Research payments

$89

Paid to them · 3 records reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Megan Urquhart of Rolling Meadows, IL is reported in the CMS Open Payments database as having received $8,083 across 337 general payments and $89 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,979 86
2024 General $2,096 86
2024 Research $89 3
2023 General $1,916 71
2022 General $1,274 56
2021 General $818 38

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Megan Urquhart
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Megan Urquhart were reported at $1,979. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Megan Urquhart Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $818 $132 $37–$438 $132
2022 $1,274 $155 $48–$522 $149
2023 $1,916 $167 $52–$557 $160
2024 $2,096 $178 $55–$600 $164
2025 $1,979 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,782 65 payments
  2. Regeneron Healthcare Solutions, Inc. $1,032 31 payments
  3. Mayne Pharma Inc. $775 32 payments
  4. E.R. Squibb & Sons, L.L.C. $590 31 payments
  5. Novartis Pharmaceuticals Corporation $526 26 payments
  6. Genzyme Corporation $521 22 payments
  7. Lilly USA, LLC $490 24 payments
  8. Amgen Inc. $326 13 payments
  9. Sun Pharmaceutical Industries Inc. $293 13 payments
  10. Incyte Corporation $283 12 payments
  11. Other $1,464 68 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,083 337 payments
Products named General payments · program years 2021–2025
  1. SKYRIZI $883 28 payments
  2. DUPIXENT Immunology $664 28 payments
  3. LIBTAYO $663 18 payments
  4. RINVOQ $610 22 payments
  5. SOTYKTU $571 30 payments
  6. DUPIXENT Inflammation And Immunology $369 13 payments
  7. HUMIRA $332 17 payments
  8. Otezla $326 13 payments
  9. OPZELURA $283 12 payments
  10. TALTZ $270 19 payments
  11. Other $2,920 142 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. AbbVie, Inc. $89 3 payments

Records

340 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record